Candel Therapeutics (CADL) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.4
-0.22
-0.05
0.13

Details

Expected EPS
-0.185189
Actual EPS
-0.21
Surprise EPS
-0.02
Surprise Percent
-13.4%

Description

⁨Candel Therapeutics⁩ (⁦CADL⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts